Prescription medication
Briefing paper
Drugs, Poisons and Controlled Substances Amendment (Authorising Pharmacists) Bill 2023: Bill Brief
This Bill Brief outlines selected aspects of proposed changes to the Drugs, Poisons and Controlled Substances Act 1981, in relation to the medicines pharmacists may be able to prescribe without a prescription and how this will impact the health system. It provides a jurisdictional comparison on what other Australian states have done in this space...
Journal article
An evaluation of the Australian Community Pharmacy Agreement from a public policy perspective
The objective of this paper is to determine the true nature of a series of Community Pharmacy Agreements between the Federal Government and the Pharmacy Guild of Australia and whether these agreements serve the public’s access and use of medicines. The paper concludes that the Agreements can be characterised predominantly as industry policy benefiting pharmacy...
Systematic review
Pharmacy practice in emergency response during the COVID-19 pandemic: lessons from Australia
The purpose of this paper is to provide an overview of the pharmacy practice and initiatives taken by the Australian federal government to ensure the continued supply of essential medicines under the conditions of an emergency response plan for COVID-19.
Report
Patient power: unleashing choice over routine medications
This report finds that many patients are not fully aware of the level of control they are entitled to when it comes to choosing medication. It suggests that pharmacists could play a greater role in the patient care pathway to support patients make choices about their medication, where doctors do not have the time or...
Report
Fentanyl availability on darknet markets
The convergence of anonymous online illicit darknet markets (or cryptomarkets) and cryptocurrencies, such as Bitcoin, has created an efficient retail platform for illicit markets, including potent new synthetic opioids such as fentanyl.